trending Market Intelligence /marketintelligence/en/news-insights/trending/6Z8VMZSQDtm5qH3-5BUDUQ2 content esgSubNav
In This List

Ohr Pharmaceutical closes upsized common stock, warrants offering

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Ohr Pharmaceutical closes upsized common stock, warrants offering

Ohr Pharmaceutical Inc. closed its public offering of common stock and warrants.

The company sold 3,885,000 common shares at a price of $2.00 per share. Investors also received series A warrants to purchase 1,942,500 common shares and series B warrants for 3,885,000 shares.

Ohr previously offered 3,875,000 common shares, series A warrants for 1,937,500 common shares and series B warrants for 3,875,000 common shares.

Series A warrants have a term of five years and an exercise price of $2.75 per share, and the series B warrants have a term of six months and an exercise price of $3.00 apiece. Both series of warrants are exercisable immediately.

The offering generated gross proceeds to the company of about $7.8 million, excluding proceeds from the exercise of warrants.

H.C. Wainwright & Co. LLC was the exclusive placement agent for the offering.